NCT00244816 2025-10-23
Taxoprexin® Treatment for Advanced Eye Melanoma
American Regent, Inc.
Phase 2 Completed
Clinical Trials
5 trialsNCT00249262 2025-09-26
Taxoprexin Treatment for Advanced Skin Melanoma
American Regent, Inc.
Phase 2 Completed
NCT01849250 2021-12-28
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
National Cancer Institute (NCI)
Phase 2 Completed
NCT01051154 2016-08-22
DHA-ALL
Coordinación de Investigación en Salud, Mexico
Phase 2 Completed
NCT01070355 2011-10-21
EMT
University of Leeds
Phase 2 Completed